相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A review of human vaccine research and development: Malaria
Marc P. Girard et al.
VACCINE (2007)
Adjuvant activity of polymer microparticles and Montanide ISA 720 on immune responses to Plasmodium falciparum MSP2 long synthetic peptides in mice
E. Mata et al.
VACCINE (2007)
A DNA prime-modified vaccinia virus Ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge
S. J. Dunachie et al.
INFECTION AND IMMUNITY (2006)
Progress towards the development of malaria vaccines
Elissa Malkin et al.
TRENDS IN PARASITOLOGY (2006)
Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic area
P Bejon et al.
VACCINE (2006)
Plasmodium falciparum:: Chondroitin sulfate A is the major receptor for adhesion of parasitized erythrocytes in the placenta
Michal Fried et al.
EXPERIMENTAL PARASITOLOGY (2006)
Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya
P Bejon et al.
CLINICAL INFECTIOUS DISEASES (2006)
Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers
DP Webster et al.
VACCINE (2006)
Dynamics of Anti-VAR2CSA immunoglobulin G response in a cohort of senegalese pregnant women
NGT Ndam et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Microparticle-based technologies for vaccines
Derek T. O'Hagan et al.
METHODS (2006)
Pre-erythrocytic malaria vaccines: towards greater efficacy
AVS Hill
NATURE REVIEWS IMMUNOLOGY (2006)
Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen
R Audran et al.
INFECTION AND IMMUNITY (2005)
Topical application of plasmid DNA to mouse and human skin
N Meykadeh et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum
P Druilhe et al.
PLOS MEDICINE (2005)
Evaluation of three Pichia pastoris-expressed Plasmodium falciparum merozoite proteins as a combination vaccine against infection with blood-stage parasites
DM Zhang et al.
INFECTION AND IMMUNITY (2005)
Cationic liposomes containing mycobacterial lipids: a new powerful Th1 adjuvant system
I Rosenkrands et al.
INFECTION AND IMMUNITY (2005)
Safety and immunogenicty of RTS,S/AS02A candidate malaria vaccine in Gambian children
KA Bojang et al.
VACCINE (2005)
A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant
A Saul et al.
VACCINE (2005)
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara
DP Webster et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
MHC class I-restricted exogenous presentation of a synthetic 102-mer malaria vaccine polypeptide
S Prato et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Genetically modified Plasmodium parasites as a protective experimental malaria vaccine
AK Mueller et al.
NATURE (2005)
Safety, immunogenicity and efficacy of a pre-erythrocytic malaria candidate vaccine, ICC-1132 formulated in Seppic ISA 720
M Walther et al.
VACCINE (2005)
Vaccine-induced immunity to malaria parasites and the need for novel strategies
MF Good
TRENDS IN PARASITOLOGY (2005)
A CD4+ T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease
WHH Reece et al.
NATURE MEDICINE (2004)
Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles
AM Carcaboso et al.
VACCINE (2004)
Influenza virosomes enhance class I restricted CTL induction through CD4+T cell activation
R Schumacher et al.
VACCINE (2004)
Pre-clinical evaluation of the malaria vaccine candidate P-falciparum MSP142 formulated with novel adjuvants or with alum
S Pichyangkul et al.
VACCINE (2004)
Composition and surface charge of DNA-loaded microparticles determine maturation and cytokine secretion in human dendritic cells
S Jilek et al.
PHARMACEUTICAL RESEARCH (2004)
Association between protection, against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendernicity in myanmar: Complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein
S Soe et al.
INFECTION AND IMMUNITY (2004)
A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults
VS Moorthy et al.
PLOS MEDICINE (2004)
Progress in DNA-based heterologous prime-boost immunization strategies for malaria
AC Moore et al.
IMMUNOLOGICAL REVIEWS (2004)
Topical vaccination of DNA antigens: Topical delivery of DNA antigens
MJ Choi et al.
SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY (2003)
Induction of parasite growth-inhibitory antibodies by a virosomal formulation of a peptidomimetic of loop I from domain III of Plasmodium falciparum apical membrane antigen 1
MS Mueller et al.
INFECTION AND IMMUNITY (2003)
In vivo study of the GC90/IRIV vaccine for immune response and autoimmunity into a novel humanised transgenic mouse
A Scardino et al.
BRITISH JOURNAL OF CANCER (2003)
Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes
VP Torchilin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Influenza virosomes: combining optimal presentation of hemagglutinin with immunopotentiating activity
A Huckriede et al.
VACCINE (2003)
Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines
J Bramson et al.
GENE THERAPY (2003)
Novel approaches in the development of immunopotentiating reconstituted influenza virosomes as efficient antigen carrier systems
R Glück et al.
VACCINE (2003)
Induction of protective immunity against malaria by priming-boosting immunization with recombinant cold-adapted influenza and modified vaccinia Ankara viruses expressing a CD8(+)-T-cell epitope derived from the circumsporozoite protein of Plasmodium yoelii
G Gonzalez-Aseguinolaza et al.
JOURNAL OF VIROLOGY (2003)
Differential localization of processed fragments of Plasmodium falciparum serine repeat antigen and further processing of its N-terminal 47 kDa fragment
H Li et al.
PARASITOLOGY INTERNATIONAL (2002)
Influenza virosomes are an efficient delivery system for respiratory syncytial virus-F antigen inducing humoral and cell-mediated immunity
MG Cusi et al.
VACCINE (2002)
Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo
KD Newman et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH (2002)
In vitro studies of core peptide-bearing immunopotentiating reconstituted influenza virosomes as a non-live prototype vaccine against hepatitis C virus
IP Hunziker et al.
INTERNATIONAL IMMUNOLOGY (2002)
Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites
SL Hoffman et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Delivery of protein antigens to the immune system by fusion-active virosomes: A comparison with liposomes and ISCOMs
L Bungener et al.
BIOSCIENCE REPORTS (2002)
A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea
B Genton et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Delayed-type hypersensitivity in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites
JG Kublin et al.
VACCINE (2002)
In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres
S Prior et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Plasmodium vivax malaria vaccine development
M Arévalo-Herrera et al.
MOLECULAR IMMUNOLOGY (2001)
Tumour-associated antigen (TAA)-specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes
P Correale et al.
EUROPEAN JOURNAL OF CANCER (2001)
Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen
O Bruña-Romera et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells
E Walter et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Induction of CD4+ T cell-dependent CD8+ type 1 responses in humans by a malaria DNA vaccine
RB Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine
SE Parker et al.
GENE THERAPY (2001)
Antibodies against merozoite surface protein (MSP)-119 are a major component of the invasion-inhibitory response in individuals immune to malaria
RA O'Donnell et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
DNA-based vaccines against malaria: status and promise of the multi-stage malaria DNA vaccine operation
DL Doolan et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2001)
Pre-erythrocytic immunity to Plasmodium falciparum:: the case for an LSA-1 vaccine
JD Kurtis et al.
TRENDS IN PARASITOLOGY (2001)
Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein
MG Cusi et al.
VIRUS RESEARCH (2001)
Adjuvants designed for veterinary and human vaccines
J Aucouturier et al.
VACCINE (2001)
Child mortality and malaria transmission intensity in Africa
TA Smith et al.
TRENDS IN PARASITOLOGY (2001)
Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria
KE Kester et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen
TR Jones et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid: Plasmid DNA complexes in mice
JD Tousignant et al.
HUMAN GENE THERAPY (2000)
Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes
H Hisaeda et al.
INFECTION AND IMMUNITY (2000)
Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes
EH Nardin et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved preerythrocytic liver-stage antigen 3
P Daubersies et al.
NATURE MEDICINE (2000)
α-Galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria
G Gonzalez-Aseguinolaza et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Liposome-mediated cytosolic delivery of macromolecules and its possible use in vaccine development
M Owais et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Molecular characterisation of Plasmodium reichenowi apical membrane antigen-1 (AMA-1), comparison with P-falciparum AMA-1, and antibody-mediated inhibition of red cell invasion
CHM Kocken et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2000)
Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination
P Johansen et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2000)
The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells
G De Becker et al.
INTERNATIONAL IMMUNOLOGY (2000)
Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers
TP Le et al.
VACCINE (2000)
Naturally acquired antibodies to the glutamate-rich protein are associated with protection against Plasmodium falciparum malaria
D Dodoo et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes
S Dokka et al.
PHARMACEUTICAL RESEARCH (2000)
Tissue distribution and persistence in mice of plasmid DNA encapsulated in a PLGA-based microsphere delivery vehicle
L Lunsford et al.
JOURNAL OF DRUG TARGETING (2000)
分享论文
